Drugs: A multi-billion-dollar industry that fuels crime and violence like no other substance on the planet. Turning cartel leaders into billionaires, the illegal drug industry also provides vital income to hundreds of thousands of poor workers across the globe. While some users sacrifice their lives to an addiction they can't escape, others find drugs to be their only saving grace from physical or emotional pain almost impossible to overcome. Where should the lines be drawn in this lucrative industry?

Drugs, Inc. - Netflix

Type: Documentary

Languages: English

Status: Running

Runtime: 60 minutes

Premier: 2010-07-11

Drugs, Inc. - Amgen - Netflix

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the world's largest independent biotechnology firm. In 2013, the company's largest selling product lines were Neulasta/Neupogen, two closely related drugs used to prevent infections in patients undergoing cancer chemotherapy; and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.

Drugs, Inc. - History - Netflix

The word AMGen is a portmanteau of the company's original name, Applied Molecular Genetics, which became the official name of the company in 1983 (three years after incorporation and coincident with its initial public offering). The company's first chief executive officer, from 1980, was co-founder George B. Rathmann, followed by Gordon M. Binder in 1988, followed by Kevin W. Sharer in 2000. Robert A. Bradway became Amgen’s president and chief executive officer in May 2012 following Sharer's retirement. The company has made at least five major corporate acquisitions.

Drugs, Inc. - References - Netflix